CFTR and cystic fibrosis: Recent advances in pharmacological agents such as CFTR correctors and potentiators (reviewed in Gentzsch et al. (2018) and Burgener et al. (2018)) [5,6] and other medical advancements, including lung transplantation, have extended the mean survival of CF patients.